Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Foie
»
Néoplasie
02. Octobre 2025
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 3658
Articles 1 - 20 / 73159
Improving the accuracy and precision of disease identification when utilizing EHR data for research: the case for hepatocellular carcinoma.
BMC Res Notes
Wong CR, Flores YN, Avila A, Tieu L, Crespi CM, May FP, Bell DS, Glenn B, Bastani R.
PMID: 41035064 [PubMed - indexed for MEDLINE]
CaracterÃsticas clÃnicas y de imagen en pacientes con cirrosis y carcinoma hepatocelular en un hospital de tercer nivel de Córdoba.
Rev Fac Cien Med Univ Nac Cordoba
Oliva V, Muiño G, Orozco S, Saad EJ.
PMID: 41032430 [PubMed - indexed for MEDLINE]
Paraneoplastic Dermatomyositis in Patient with Primary Biliary Cirrhosis and Hepatocellular Carcinoma: A Case Report.
Am J Case Rep
Neycheva S, Stoyanova D.
PMID: 41029813 [PubMed - indexed for MEDLINE]
Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: outcomes and prognostic factors.
Radiat Oncol
Lee SJ, Kim M.
PMID: 41029751 [PubMed - indexed for MEDLINE]
RNA methylation in hepatocellular carcinoma: from metabolic reprogramming and immune escape mechanisms to small molecule inhibitor development.
J Transl Med
Xu Y, Lan F, Yang C, Li P.
PMID: 41029638 [PubMed - indexed for MEDLINE]
Global trends and regional differences of hepatoblastoma: a systematic analysis and predictions to 2035 based on the global burden of disease study 2021.
BMC Public Health
Shi K, Xu C, Zhang X, Liang H, Li X, Liu B, Wang Q.
PMID: 41029285 [PubMed - indexed for MEDLINE]
Preoperative HBsAg seroclearance affects long-term outcomes for hepatitis B virus-related hepatocellular carcinoma after liver resection: a multicenter analysis.
BMC Cancer
Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B, Dai MG.
PMID: 41029249 [PubMed - indexed for MEDLINE]
Lenvatinib in combination with radiotherapy versus lenvatinib with transarterial chemoembolization for advanced hepatocellular carcinoma.
BMC Cancer
Chuang WY, Shen PC, Chiu SH, Huang WY, Chang WC, Lin CS, Lo CH.
PMID: 41029243 [PubMed - indexed for MEDLINE]
Exploring therapeutic targets for hepatocellular carcinoma through druggable genes.
Medicine (Baltimore)
Tang C, Zhu S, Ding Z.
PMID: 41029168 [PubMed - indexed for MEDLINE]
Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.
Radiology
Wessner CE, Forsberg F, Lyshchik A, O'Kane P, Bradigan K, Liu JB, Delaney LJ, Anton K, Topper SR, Civan J, Maley W, Keith SW, Shaw CM, Eisenbrey JR.
PMID: 41025990 [PubMed - indexed for MEDLINE]
Advanced-stage colorectal cancer in the context of coronavirus disease-19, highlighting socioeconomic disparities and outcomes: a case report.
J Med Case Rep
Brim H, Gonzales S, Deverapalli M, Laiyemo AO, Rashid M, Zafar R, Nembhard C, Ashktorab H.
PMID: 41024295 [PubMed - indexed for MEDLINE]
A meta-analytic and systematic review to compare perioperative outcomes and prognosis between robotic and conventional (laparoscopic or open) liver resection in hepatocellular carcinoma cases.
World J Surg Oncol
Hu L, Shi X, Wang A, Zhang F.
PMID: 41024011 [PubMed - indexed for MEDLINE]
Gd-EOB-DTPA-enhanced hepatobiliary phase MRI characteristics of inflammatory hepatic adenoma.
BMC Med Imaging
Zheng Y, Cai E, Zeng M, Wang M.
PMID: 41023616 [PubMed - indexed for MEDLINE]
Comparison of liver stereotactic body radiotherapy plans based on free breathing and averaged CTs after trans-arterial chemoembolization using lipiodol.
J Appl Clin Med Phys
Kang SK, Yoon JW, Kim MY, Park S, Cheong KH, Koo T, Han TJ.
PMID: 41023542 [PubMed - indexed for MEDLINE]
Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study.
Front Immunol
Tabuchi T, Taniki N, Ojiro K, Kasuga R, Nakadai Y, Chu PS, Usui S, Shiba S, Tahara T, Komatsu H, Fujita Y, Kaneko F, Hoshi H, Yamaguchi A, Fukuhara S, Okamura Y, Kanamori H, Ebinuma H, Tamura M, Tsukada J, Hasegawa Y, Abe Y, Kitago M, Jinzaki M, Kitagawa Y, Kanai T, Nakamoto N.
PMID: 41019089 [PubMed - indexed for MEDLINE]
Air pollution-related immune gene prognostic signature for hepatocellular carcinoma: network toxicology, machine learning and multi-omics analysis.
Front Immunol
Pu L, Zhang X, Pu C, Sun P.
PMID: 41019083 [PubMed - indexed for MEDLINE]
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study.
Front Immunol
Luo W, Liu L, Lin W, Mei J, Lin Y, Yang Z, Liu F, Wei W, Guo R, Yun J.
PMID: 41019079 [PubMed - indexed for MEDLINE]
Development and Validation of a Predictive Model for Occult Liver Metastasis in Pancreatic Ductal Adenocarcinoma Using Subjective Imaging and Clinical Data.
Cancer Med
Liu JB, Gu QB, He J, Liu DJ, Long JL, Li H, Liu P.
PMID: 41017311 [PubMed - indexed for MEDLINE]
Efficacy and safety of Yangxiao Fukang granule in the treatment of stage â…¢ hepatitis B related liver cancer: study protocol for a randomized controlled trial.
J Tradit Chin Med
Shanyi LI, Qi G, Yanjie LI, Yaling Z, Xiaoqi C.
PMID: 41015811 [PubMed - indexed for MEDLINE]
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular Carcinoma.
J Gastrointest Cancer
Akyildiz A, Yavuz BG, Ismayilov R, Buyukaksoy M, Sozen S, Eid JR, Avritscher R, Sunyoung L, Yalcin S, Kaseb AO.
PMID: 41015600 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 73159
Page 1 de 3658
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité